DNAA PROTEIN AND REPLICATION INITIATION IN MYCOBACTERIA
分枝杆菌中的 DNAA 蛋白和复制起始
基本信息
- 批准号:2457822
- 负责人:
- 金额:$ 8.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-08-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
M. tuberculosis, the causative agent of tuberculosis is a well known
pathogen that has reestablished itself as a significant world wide public
health hazard. While there is a great deal of published information in
the physiology and pathogenesis of M. tuberculosis, there is very little
information available on genetic control of DNA synthesis and related
metabolism governing DNA replication. Replication of bacterial
chromosomes occurs at unique sequences called 'oriC' and is thought to
be regulated at the level of initiation. Studies on replication
initiation in other bacteria suggest that both DnaA, the initiator
protein and replication origin sequences are structurally conserved. The
replication origin is AT rich and contains repeats of nine nucleotide
long DnaA protein recognition sequences called the DnaA boxes and repeats
of 13 - 16 nucleotide long AT rich elements. The number and position of
some of the DnaA boxes is variable in each bacteria. The dnaA gene
flanking region in many bacteria supports autonomous replication
activity. The genetic and biochemical aspects of replication initiation
in mycobacteria are not known. Our research proposal focuses on
identifying the key elements needed for replication initiation in M.
tuberculosis. During the granting period M. tuberculosis dnaA gene will
be cloned and its nucleotide sequence will be determined. The nucleotide
sequence of the dnaA flanking region will be determined and putative
replication origin sequence features, if any, will be identified. The
ability of the dnaA gene flanking sequences to support autonomous
replication when present in nonreplicative plasmids will be determined.
Sequential deletions from both the 5' and the 3' end of the flanking
regions will be carried out to identify the minimal size DNA fragment
that supports autonomous replication. If dnaA gene flanking region is
not the 'oriC', then shot gun cloning approach will be used to identify
the replication origin sequences. Once M. tuberculosis oriC is
identified, then oligonucleotide primers specific to oriC will be
synthesized and used to amplify related replication origin sequences from
the genomic DNA preparations of other species of mycobacteria. The
nucleotide sequence of these replication origins will be determined and
compared to determine similarities and dissimilarities in the
organization of 'oriC' in mycobacteria. M. tuberculosis DnaA protein will
be overproduced in E. coli and the protein thus overproduced will be
purified. The interactions of DnaA protein with the DnaA boxes of the
replication origin will be established in vitro by gel retardation,
nitrocellulose and DNasel foot printing assays. Thus, by identifying the
DNA fragments that support autonomous replication and investigating the
interaction of DnaA protein with the autonomous replication sequences,
this study will establish the early events in initiation of DNA
replication in M. tuberculosis.
M.结核病,结核病的病原体是众所周知的
病原体已经重新确立了自己作为一个重要的世界范围内的公众
健康危害。 虽然有大量的公开信息,
对M.肺结核,
关于DNA合成遗传控制和相关
控制DNA复制的代谢。 细菌复制
染色体发生在称为“oriC”的独特序列上,
在初始阶段进行规范。 关于复制的研究
在其他细菌中的启动表明,启动子DnaA
蛋白质和复制起点序列在结构上是保守的。 的
复制起点富含AT并含有9个核苷酸的重复
长的DnaA蛋白识别序列称为DnaA盒和重复序列
13 - 16个核苷酸长的AT富集元件。 的数量和位置
每种细菌的某些DNA盒是可变的。 dnaA基因
许多细菌中的侧翼区支持自主复制
活动 复制起始的遗传和生物化学方面
在分枝杆菌中是未知的。 我们的研究计划集中在
确定在M中复制启动所需的关键元件。
结核 在授予期间,M。结核病dnaA基因将
克隆并测定其核苷酸序列。 的核苷酸
将确定dnaA侧翼区的序列,并推定
将鉴定复制起点序列特征(如果有的话)。 的
dnaA基因侧翼序列的能力,以支持自主
当存在于非复制型质粒中时,将测定复制。
从侧翼序列的5'和3'端的连续缺失
将进行区域鉴定,以确定最小大小的DNA片段
支持自主复制。 如果dnaA基因侧翼区是
如果不是“oriC”,则将使用鸟枪克隆的方法来识别
复制起点序列 一旦M.结核病oriC是
鉴定,然后将对oriC特异性的寡核苷酸引物
合成并用于扩增相关的复制起点序列,
其他分枝杆菌的基因组DNA制备。 的
将确定这些复制起点的核苷酸序列,
比较,以确定相似性和不同之处,
分枝杆菌中的“oriC”组织。M.结核DnaA蛋白将
在E.大肠杆菌和蛋白质,因此过度生产将是
提纯 DnaA蛋白与细胞DNA盒的相互作用
复制起点将通过凝胶阻滞在体外建立,
硝酸纤维素和DNA酶1足迹测定。 因此,通过识别
支持自主复制的DNA片段,
DnaA蛋白与自主复制序列的相互作用,
这项研究将确定DNA启动的早期事件,
在M.结核
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MALINI RAJAGOPALAN其他文献
MALINI RAJAGOPALAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MALINI RAJAGOPALAN', 18)}}的其他基金
MtrA and Mycobacterium tuberculosis proliferation
MtrA 和结核分枝杆菌增殖
- 批准号:
7038708 - 财政年份:2006
- 资助金额:
$ 8.99万 - 项目类别:
MtrA and Mycobacterium tuberculosis proliferation
MtrA 和结核分枝杆菌增殖
- 批准号:
7230008 - 财政年份:2006
- 资助金额:
$ 8.99万 - 项目类别:
CELL DIVISION IN MYCOBACTERIUM TUBERCULOSIS/FTSZ PROTEIN
结核分枝杆菌/FTSZ 蛋白的细胞分裂
- 批准号:
6532838 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
Mycobacterium tuberculosis cell division and proliferation
结核分枝杆菌细胞分裂和增殖
- 批准号:
7795874 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
CELL DIVISION IN MYCOBACTERIUM TUBERCULOSIS/FTSZ PROTEIN
结核分枝杆菌/FTSZ 蛋白的细胞分裂
- 批准号:
6213981 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
Mycobacterium tuberculosis cell division and proliferation
结核分枝杆菌细胞分裂和增殖
- 批准号:
7385872 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
Mycobacterium tuberculosis cell division and proliferation
结核分枝杆菌细胞分裂和增殖
- 批准号:
7285776 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
CELL DIVISION IN MYCOBACTERIUM TUBERCULOSIS/FTSZ PROTEIN
结核分枝杆菌/FTSZ 蛋白的细胞分裂
- 批准号:
6374658 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
CELL DIVISION IN MYCOBACTERIUM TUBERCULOSIS/FTSZ PROTEIN
结核分枝杆菌/FTSZ 蛋白的细胞分裂
- 批准号:
6748136 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
CELL DIVISION IN MYCOBACTERIUM TUBERCULOSIS/FTSZ PROTEIN
结核分枝杆菌/FTSZ 蛋白的细胞分裂
- 批准号:
6608048 - 财政年份:2000
- 资助金额:
$ 8.99万 - 项目类别:
相似海外基金
Elucidation of the life-sustaining mechanism of hyperthermophilic archaea without DNA replication origin
阐明无DNA复制起点的超嗜热古菌的生命维持机制
- 批准号:
19K22289 - 财政年份:2019
- 资助金额:
$ 8.99万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identification of the DNA replication origin in Arabidopsis
拟南芥DNA复制起点的鉴定
- 批准号:
17K19250 - 财政年份:2017
- 资助金额:
$ 8.99万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Genome-wide identification of DNA replication origin sequences in human cells
人类细胞 DNA 复制起点序列的全基因组鉴定
- 批准号:
16K12595 - 财政年份:2016
- 资助金额:
$ 8.99万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8457662 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8706908 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8665806 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
- 批准号:
8824650 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
- 批准号:
8829782 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别:
Post-translational regulation of DNA replication origin licensing in human cells
人类细胞 DNA 复制起点许可的翻译后调控
- 批准号:
10093060 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别:
Diversity Supplement: Post-Translational Regulation of DNA Replication Origin Licensing in Human Cells
多样性补充:人类细胞中 DNA 复制起点许可的翻译后调控
- 批准号:
10120875 - 财政年份:2013
- 资助金额:
$ 8.99万 - 项目类别: